ISSN: 1300-0292
İndekslendiği Dizinler: SCIENCE CITATION INDEX EXPANDED
CINAHL, Index Copernicus,
Chemical Abstracts (CA),
Excerpta Medica / EMBASE
Dil: Türkçe, İngilizce
İçerik: Orijinal Araştırma, Derleme, Editöre Mektup, Olgu Sunumu, Tıp Eğitimi, Tıbbi Kitap İncelemeleri
|
|
|
|
ORIGINAL RESEARCH ARTICLES |
Hepatic Resection For Primary And Metastatic Liver Tumors
Aydın İNAN, MD,a Cenap DENER, MD,a Meral ŞEN, MD,a Mikdat BOZER, MD,a Salim DEMİRCİ, MDb
Department of aGeneral Surgery, Fatih University School of Medicine, Department of bSurgical Oncology, Ankara University School of Medicine, ANKARA
Objective: Surgical resection is the standard treatment for malignant liver tumors and selected benign lesions. Results of hepatic resection greatly improved in the last two decades and currently are associated with low morbidity and mortality rates. We analyzed hepatic resections for primary and metastatic liver tumors in our hospital.
Material and Methods: Thirty-eight patients underwent hepatic resection for primary and secondary liver tumors between January 1998 and June 2004. We evaluated patients’ characteristics, indications for resections, complications, morbidity and mortality.
Results: Twenty-six percent of patients were operated for primary and 74% for metastatic liver tumors. One patient with cholangiocellular carcinoma who had been treated with left hepatectomy developed recurrence on month 14. Operative mortality developed in one patient who had undergone right hepatectomy for metastasis from adenocarcinoma of the caecum. Mean follow-up period was 34 months. Five (13.5%) patients died during this period.
Conclusion: Hepatic resection offers a long-term survival and potential cure for patients with malignant primary or secondary liver tumors. There has been a gradual increase in the number of hepatic resections for primary and secondary liver tumors with low morbidity and mortality rates.Keywords: Liver; liver neoplasmsTurkiye Klinikleri J Med Sci 2007, 27:52-58
|
|
|
|
|
